Literature DB >> 20068018

Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells.

S G Thacker1, D Duquaine, J Park, M J Kaplan.   

Abstract

Patients with systemic lupus erythematosus (SLE) have an impairment in phenotype and function of endothelial progenitor cells (EPCs) which is mediated by interferon alpha (IFN-alpha). We assessed whether murine lupus models also exhibit vasculogenesis abnormalities and their potential association with endothelial dysfunction. Phenotype and function of EPCs and type I IFN gene signatures in EPC compartments were assessed in female New Zealand Black/New Zealand White F(1) (NZB/W), B6.MRL-Fas(lpr)/J (B6/lpr) and control mice. Thoracic aorta endothelial and smooth muscle function were measured in response to acetylcholine or sodium nitropruside, respectively. NZB/W mice displayed reduced numbers, increased apoptosis and impaired function of EPCs. These abnormalities correlated with significant decreases in endothelium-dependent vasomotor responses and with increased type I IFN signatures in EPC compartments. In contrast, B6/lpr mice showed improvement in endothelium-dependent and endothelial-independent responses, no abnormalities in EPC phenotype or function and downregulation of type I IFN signatures in EPC compartments. These results indicate that NZB/W mice represent a good model to study the mechanisms leading to endothelial dysfunction and abnormal vasculogenesis in lupus. These results further support the hypothesis that type I IFNs may play an important role in premature vascular damage and, potentially, atherosclerosis development in SLE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20068018      PMCID: PMC3151666          DOI: 10.1177/0961203309353773

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  53 in total

1.  Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus.

Authors:  Michael J Ryan; Gerald R McLemore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-03       Impact factor: 3.619

2.  Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells.

Authors:  Shoukang Zhu; Xialin Liu; Ying Li; Pascal J Goldschmidt-Clermont; Chunming Dong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-09       Impact factor: 8.311

3.  ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia.

Authors:  Xuebing Feng; Hongyun Li; Alexis A Rumbin; Xuping Wang; Antonio La Cava; Katherine Brechtelsbauer; Lawrence W Castellani; Joseph L Witztum; Aldons J Lusis; Betty P Tsao
Journal:  J Lipid Res       Date:  2007-01-26       Impact factor: 5.922

4.  Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.

Authors:  Peter E Westerweel; Remco K M A C Luijten; Imo E Hoefer; Hein A Koomans; Ronald H W M Derksen; Marianne C Verhaar
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

5.  Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.

Authors:  Q Lu; N Shen; X M Li; S L Chen
Journal:  Genes Immun       Date:  2007-08-30       Impact factor: 2.676

6.  Deficiency of the type I interferon receptor protects mice from experimental lupus.

Authors:  Dina C Nacionales; Kindra M Kelly-Scumpia; Pui Y Lee; Jason S Weinstein; Robert Lyons; Eric Sobel; Minoru Satoh; Westley H Reeves
Journal:  Arthritis Rheum       Date:  2007-11

7.  Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus.

Authors:  Pui Y Lee; Yi Li; Hanno B Richards; Fay S Chan; Haoyang Zhuang; Sonali Narain; Edward J Butfiloski; Eric S Sobel; Westley H Reeves; Mark S Segal
Journal:  Arthritis Rheum       Date:  2007-11

8.  The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.

Authors:  Matthew D Silverman; Christian S Haas; Ali M Rad; Ali S Arbab; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2007-06

Review 9.  Recipes for creating animal models of diabetic cardiovascular disease.

Authors:  Willa Hsueh; E Dale Abel; Jan L Breslow; Nobuyo Maeda; Richard C Davis; Edward A Fisher; Hayes Dansky; Donald A McClain; Richard McIndoe; Momtaz K Wassef; Cristina Rabadán-Diehl; Ira J Goldberg
Journal:  Circ Res       Date:  2007-05-25       Impact factor: 17.367

10.  Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis.

Authors:  Michael F Denny; Seth Thacker; Hemal Mehta; Emily C Somers; Todd Dodick; Franck J Barrat; W Joseph McCune; Mariana J Kaplan
Journal:  Blood       Date:  2007-07-16       Impact factor: 25.476

View more
  35 in total

1.  How does interferon-α insult the vasculature? Let me count the ways.

Authors:  Mariana J Kaplan; Jane E Salmon
Journal:  Arthritis Rheum       Date:  2011-02

2.  Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.

Authors:  Robert C Grenn; Srilakshmi Yalavarthi; Alex A Gandhi; Nayef M Kazzaz; Carlos Núñez-Álvarez; Diego Hernández-Ramírez; Antonio R Cabral; W Joseph McCune; Paula L Bockenstedt; Jason S Knight
Journal:  Ann Rheum Dis       Date:  2016-07-18       Impact factor: 19.103

3.  A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity.

Authors:  Carmelo Carmona-Rivera; Monica M Purmalek; Erica Moore; Meryl Waldman; Peter J Walter; H Martin Garraffo; Karran A Phillips; Kenzie L Preston; Jonathan Graf; Mariana J Kaplan; Peter C Grayson
Journal:  JCI Insight       Date:  2017-02-09

4.  An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage.

Authors:  J Michelle Kahlenberg; Srilakshmi Yalavarthi; Wenpu Zhao; Jeffrey B Hodgin; Tamra J Reed; Noriko M Tsuji; Mariana J Kaplan
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

5.  Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.

Authors:  J Michelle Kahlenberg; Seth G Thacker; Celine C Berthier; Clemens D Cohen; Matthias Kretzler; Mariana J Kaplan
Journal:  J Immunol       Date:  2011-11-04       Impact factor: 5.422

Review 6.  Why are kids with lupus at an increased risk of cardiovascular disease?

Authors:  Catherine Quinlan; Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-09-23       Impact factor: 3.714

Review 7.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

8.  High dietary fat promotes visceral obesity and impaired endothelial function in female mice with systemic lupus erythematosus.

Authors:  Emily L Gilbert; Michael J Ryan
Journal:  Gend Med       Date:  2011-04

9.  Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.

Authors:  Jason S Knight; Wei Luo; Alexander A O'Dell; Srilakshmi Yalavarthi; Wenpu Zhao; Venkataraman Subramanian; Chiao Guo; Robert C Grenn; Paul R Thompson; Daniel T Eitzman; Mariana J Kaplan
Journal:  Circ Res       Date:  2014-01-14       Impact factor: 17.367

10.  Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.

Authors:  Jason S Knight; Venkataraman Subramanian; Alexander A O'Dell; Srilakshmi Yalavarthi; Wenpu Zhao; Carolyne K Smith; Jeffrey B Hodgin; Paul R Thompson; Mariana J Kaplan
Journal:  Ann Rheum Dis       Date:  2014-08-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.